Literature DB >> 17008364

Irritable bowel syndrome in twins: genes and environment.

M-B Bengtson1, T Rønning, M H Vatn, J R Harris.   

Abstract

BACKGROUND AND AIMS: Both environmental and genetic factors may contribute to irritable bowel syndrome (IBS). Nutrition in fetal life, an early environmental factor, seems to influence the development of chronic diseases later in life, such as coronary heart disease, hypertension, and non-insulin diabetes. This population based twin study evaluated the association between intrauterine growth, measured by weight and gestational age, and IBS. Structural equation analyses were conducted to analyse genetic and environmental sources of variation in liability to IBS.
METHODS: A postal questionnaire was sent to 12 700 Norwegian twins born between 1967 and 1979. The questionnaire included a checklist of 31 illnesses and symptoms, including IBS. The influence of birth weight on developing IBS was tested in four weight groups. Disease discordant monozygotic (MZ) pairs were analysed to test the association between intrauterine growth and IBS.
RESULTS: Concordance for IBS was significantly greater (p = 0.011) in monozygotic (22.4%) than in dizygotic (9.1%) twins. The heritability of IBS was estimated to be 48.4% among females. Birth weight below 1500 g (adjusted odds ratio 2.4 (95% confidence interval 1.1, 5.3)) contributed significantly to the development of IBS, which appeared 7.7 years earlier than in higher weight groups. In the MZ group with birth weights lower than 2500 g, twins with IBS were significantly lighter than twins without disease (190.6 g; p = 0.02).
CONCLUSION: The present study demonstrates that restricted fetal growth has a significant influence on the development of IBS later in life. Weight below 1500 g influences age at onset. Genetic contribution appears to be important for IBS among females.

Entities:  

Mesh:

Year:  2006        PMID: 17008364      PMCID: PMC1856463          DOI: 10.1136/gut.2006.097287

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  23 in total

1.  Cardiovascular mortality in twins and the fetal origins hypothesis.

Authors:  K Christensen; A Wienke; A Skytthe; N V Holm; J W Vaupel; A I Yashin
Journal:  Twin Res       Date:  2001-10

Review 2.  The Norwegian Institute of Public Health Twin Panel: a description of the sample and program of research.

Authors:  Jennifer R Harris; Per Magnus; Kristian Tambs
Journal:  Twin Res       Date:  2002-10

3.  Evaluation of analyses of univariate discrete twin data.

Authors:  Patrick F Sullivan; Lindon J Eaves
Journal:  Behav Genet       Date:  2002-05       Impact factor: 2.805

4.  Gender and irritable bowel syndrome: the male connection.

Authors:  Albena Halpert; Douglas Drossman
Journal:  J Clin Gastroenterol       Date:  2004-08       Impact factor: 3.062

5.  What is twin birthweight discordance?

Authors:  R M Patterson; R C Wood
Journal:  Am J Perinatol       Date:  1990-07       Impact factor: 1.862

6.  Gestational evolution of small intestine motility in preterm and term infants.

Authors:  C L Berseth
Journal:  J Pediatr       Date:  1989-10       Impact factor: 4.406

7.  Classification of twins and neonatal morbidity.

Authors:  R Bronsteen; G Goyert; S Bottoms
Journal:  Obstet Gynecol       Date:  1989-07       Impact factor: 7.661

Review 8.  Colonic myoelectric activity in the irritable bowel syndrome.

Authors:  W J Snape; G M Carlson; S Cohen
Journal:  Gastroenterology       Date:  1976-03       Impact factor: 22.682

9.  Predicting zygosity in Norwegian twin pairs born 1915-1960.

Authors:  P Magnus; K Berg; W E Nance
Journal:  Clin Genet       Date:  1983-08       Impact factor: 4.438

Review 10.  Glucose and insulin metabolism in twins: influence of zygosity and birth weight.

Authors:  P Poulsen; A Vaag
Journal:  Twin Res       Date:  2001-10
View more
  68 in total

Review 1.  Irritable bowel syndrome: methods, mechanisms, and pathophysiology. Genetic epidemiology and pharmacogenetics in irritable bowel syndrome.

Authors:  Michael Camilleri; David A Katzka
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2012-03-08       Impact factor: 4.052

2.  Association between early adverse life events and irritable bowel syndrome.

Authors:  Kara Bradford; Wendy Shih; Elizabeth J Videlock; Angela P Presson; Bruce D Naliboff; Emeran A Mayer; Lin Chang
Journal:  Clin Gastroenterol Hepatol       Date:  2011-12-16       Impact factor: 11.382

3.  Familial aggregation of irritable bowel syndrome: a family case-control study.

Authors:  Yuri A Saito; Gloria M Petersen; Joseph J Larson; Elizabeth J Atkinson; Brooke L Fridley; Mariza de Andrade; G Richard Locke; Janice M Zimmerman; Ann E Almazar-Elder; Nicholas J Talley
Journal:  Am J Gastroenterol       Date:  2010-03-16       Impact factor: 10.864

Review 4.  IBS: An epigenetic perspective.

Authors:  Timothy G Dinan; John Cryan; Fergus Shanahan; P W Napoleon Keeling; Eamonn M M Quigley
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2010-06-29       Impact factor: 46.802

5.  Importance of trauma-related fear in patients with irritable bowel syndrome and early adverse life events.

Authors:  Harman Rahal; Elizabeth J Videlock; Adriane Icenhour; Wendy Shih; Bruce Naliboff; Arpana Gupta; Emeran A Mayer; Lin Chang
Journal:  Neurogastroenterol Motil       Date:  2020-06-17       Impact factor: 3.598

6.  Challenges and prospects for pharmacotherapy in functional gastrointestinal disorders.

Authors:  Gareth J Sanger; Lin Chang; Chas Bountra; Lesley A Houghton
Journal:  Therap Adv Gastroenterol       Date:  2010-09       Impact factor: 4.409

7.  Chronic pain, overweight, and obesity: findings from a community-based twin registry.

Authors:  Lisa Johnson Wright; Ellen Schur; Carolyn Noonan; Sandra Ahumada; Dedra Buchwald; Niloofar Afari
Journal:  J Pain       Date:  2010-03-24       Impact factor: 5.820

Review 8.  Genes and environment in irritable bowel syndrome: one step forward.

Authors:  N J Talley
Journal:  Gut       Date:  2006-12       Impact factor: 23.059

Review 9.  Global burden of irritable bowel syndrome: trends, predictions and risk factors.

Authors:  Christopher J Black; Alexander C Ford
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2020-04-15       Impact factor: 46.802

Review 10.  Therapeutic strategies for functional dyspepsia and irritable bowel syndrome based on pathophysiology.

Authors:  Nicholas J Talley; Gerald Holtmann; Marjorie M Walker
Journal:  J Gastroenterol       Date:  2015-04-29       Impact factor: 7.527

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.